Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Bawag Cap FD TR 7,125% - Couponrendement ruim 19,8%
Volgen
Bijgevoegd een overzicht van een aantal obligaties van Bawag. Zoals de lijst weergeeft, staan de koersen om en nabij de nominale waarde (100%). In de meeste van deze obligaties heeft op 5 augustus handel plaatsgevonden. De koers van Bawag Cap FD TR 7,125% staat echter op E. 8,99. De nominale waarde is E. 25,00. De huidige waardering komt overeen met 35,96% van de nominale waarde. Het dividend bedraagt 7,125% over de nominale waarde, dus E. 1,78125. De huidige koers is E. 8,99. Het dividendrendement is dus 19,81%.
ISIN-code: DE0008600966. Fondscode: 45552.
bawag? nog nooit van gehoord
Oostenrijkse bank, zit nogal in oost europa.
Witte Weduwe schreef:
Oostenrijkse bank, zit nogal in oost europa.
Deze activiteiten zijn grootendeels verkocht. '[...] Sale of non-core business activities largely complete A central part of the Bank’s new strategy announced in 2007 was the sale of all non-core businesses. Implementation of the strategy was largely completed in 2008 with the sale of the Bank’s subsidiaries in Slovakia and the Czech Republic, as well as the sale of real estate assets. The decision to dispose of the Bank subsidiaries operating in Central and Eastern Europe reflected the desire to concentrate scarce resources on the core Austrian market, as well as a focus on building liquidity and capital. The sale process proved to be both well timed and highly successful. As a consequence, the Bank has reduced its exposure to Central and Eastern Europe to less than 5 per cent of total assets. Strong liquidity position The turmoil in the global financial markets emphasised the crucial importance of liquidity management. During 2008, BAWAG P.S.K. took further steps to maximise its available liquidity. Total cash and unutilised collateral resources at 31 December 2008 amounted to EUR 6.2 billion. This strong liquidity position represents a source of competitive advantage for the Bank, offering the opportunity to acquire high-margin banking assets that become available in the market, whilst supporting the Bank’s strategy of supporting Austrian retail and commercial customers. [...]'
PREFACE BY THE CHAIRMAN OF THE MANAGING BOARD Strong Momentum in the Core Austrian Business despite Turbulent Market Conditions In 2008, BAWAG P.S.K. continued to make good progress in executing the multi-year Transformation Programme to improve operational performance and drive profitable growth agreed with the Supervisory Board in 2007. The primary focus for the Bank remains unaltered: to modernise the core Austrian retail and commercial banking business in order to deliver outstanding service to our customers. The financial results for 2008 were heavily influenced by two factors: the progress made in improving profitability in the core Austrian business; and the combined net adverse impact arising from the re-structuring of the balance sheet and the reduction in the fair value of the Bank’s financial assets as a consequence of the global financial crisis. Underlying pro-forma pre-tax profits for 2008 grew by 82 per cent over the comparable result in 2007, market share gains were recorded in the core retail business, lending and income momentum accelerated in the commercial business, non-core assets were successfully sold and the balance sheet continued to be re-structured in line with the Bank’s reduced risk appetite. The consequence of these actions was a significant growth in the Bank’s liquidity and capital resources that allowed BAWAG P.S.K. to withstand the impact of the global economic crisis. Aggressive actions were taken throughout the year to reduce risk. However, the bankruptcy of Lehman Brothers Inc. on 15 September 2008 caused market conditions to worsen dramatically in the fourth quarter of 2008 leading to significant mark-to-market valuation losses arising in the legacy structured credit portfolio. The Bank recorded a consolidated loss after tax of EUR 452 million in the period from September to December 2008, following the dramatic change in market conditions after the bankruptcy of Lehman Brothers. This resulted in a full year loss of EUR 548 million for 2008. Underlying pre-tax operating profit up 82 per cent Underlying pre-tax profit, excluding the impact of the global financial crisis, grew by 82 per cent. Total underlying income grew by 4 per cent, with particularly strong gains recorded in net interest income, up 13 per cent. Performance was particularly strong in the core retail franchise: * Customer numbers increased by 10 per cent; * Retail savings balances across the Group increased by EUR 1.1 billion, or 8 per cent; * Premium income from new insurance contracts rose by EUR 320 million, or 19 per cent; * Gains were recorded in market share, client satisfaction and willingness to recommend; * easybank sales, balances and income were all at record levels. Progress was also evident in the commercial business: lending increased by 11 per cent, notwithstanding higher margins and a difficult environment. This customer segment offers significant potential for future profit growth. The Bank took a very defensive stance to deploying liquidity in the second half of 2008. This strategy, whilst prudent given the economic environment, was a drag on earnings in the period as investments were made of very short-term duration in a time when market interest rates were falling rapidly. Underlying expenses fell by 3 per cent, after accounting for higher investment in the on-going business. Significant changes were made to the business model, with implementation of a clear separation between front-office sales and service activities, back-office operations and risk management. These changes lay the foundation for future operational, productivity and service improvements. Underlying risk provisions were flat. Sale of non-core business activities largely complete A central part of the Bank’s new strategy announced in 2007 was the sale of all non-core businesses. Implementation of the strategy was largely completed in 2008 with the sale of the Bank’s subsidiaries in Slovakia and the Czech Republic, as well as the sale of real estate assets. The decision to dispose of the Bank subsidiaries operating in Central and Eastern Europe reflected the desire to concentrate scarce resources on the core Austrian market, as well as a focus on building liquidity and capital. The sale process proved to be both well timed and highly successful. As a consequence, the Bank has reduced its exposure to Central and Eastern Europe to less than 5 per cent of total assets. Strong liquidity position The turmoil in the global financial markets emphasised the crucial importance of liquidity management. During 2008, BAWAG P.S.K. took further steps to maximise its available liquidity. Total cash and unutilised collateral resources at 31 December 2008 amounted to EUR 6.2 billion. This strong liquidity position represents a source of competitive advantage for the Bank, offering the opportunity to acquire high-margin banking assets that become available in the market, whilst supporting the Bank’s strategy of supporting Austrian retail and commercial customers. Continued mark-to-market fair value adjustments and write-downs on financial assets and liabilities, particularly in the structured credit portfolio.
Uitstekende tip BP5. Voor zover ik dat kan beoordelen blijven alle oostenrrijkse perpen wat achter bij de recente koersstijging. RZB, BA en OVAG. De laatste is niet zo verwonderlijk gezien de matige resultaten, maar de eerste twee laten nog steeds goede cijfers zien. Voor meer tips houd ik mij aanbevolen. Nogmaals dank PS de laataste dagen goed kunnen inslaan met koersen even boven de 9,00
Beursplein, je kan je naam beter veranderen in "Junkbond-trader". Waarom start je niet je eigen draadje, maak een mooie portefeuille en houd je resultaten bij? Zoiets dat Marique ook doet met aandelen, dan zou ik het zeker wel gaan volgen.
lookingcharts schreef:
Beursplein, je kan je naam beter veranderen in "Junkbond-trader". Waarom start je niet je eigen draadje, maak een mooie portefeuille en houd je resultaten bij? Zoiets dat Marique ook doet met aandelen, dan zou ik het zeker wel gaan volgen.
De couponbetalingen op aandelen Bawag Cap FD TR 7,125% zijn gegarandeerd. Uw commentaar is dus niet van toepassing.
lookingcharts schreef:
Beursplein, je kan je naam beter veranderen in "Junkbond-trader". Waarom start je niet je eigen draadje, maak een mooie portefeuille en houd je resultaten bij? Zoiets dat Marique ook doet met aandelen, dan zou ik het zeker wel gaan volgen.
Junkbond zijn dat niet obligaties met een lage rating? Moody's lange termijn rating is mi baa1. Rating van deze stukken bij mij niet bekend maar zal hier mogelijk 1 of 2 stappen onder zitten
Huidige koers: E. 9,09. Couponrendement: ca. 19,5% netto.
Netto? Hoewerkt de interest belasting?
liguolong schreef:
Netto? Hoewerkt de interest belasting?
Volgens mij heft Oostenrijk geen bronbelasting op deze interestbetalingen. Wellicht kan iemand die recent interest heeft ontvangen eea bevestigen (anders zoek ik het wel even uit). Netto dus, al moet de waarde van de obligatie uiteraard wel in box 3 worden meegenomen.
Je krijgt het netto uitbetaald. 0,445 euro per aandeel ieder kwartaal.
BP5, je vervalt in herhaling:www.iex.nl/forum/topic.asp?forum=23&t... Wil je met ons delen wat je positie is ?
shhh! in dat draadje stond veel te veel vervelende informatie, zoals een link naar de prospectus :)Rothschild13 schreef:
BP5, je vervalt in herhaling:
www.iex.nl/forum/topic.asp?forum=23&t... Wil je met ons delen wat je positie is ?
De slotkoers is vandaag E. 9,10. Positie: ruim 23.000 aandelen.
nou, erg eerlijk hoor. Dan vang je dus ruim 10k/kwartaal. Daar kun je van leven (althans ik kan daar van leven).
liguolong schreef:
Netto? Hoewerkt de interest belasting?
Het gaat hier bij een couponbetaling, zoals bij een obligatie, dus er wordt geen belasting geheven.
Er is nu nog een vaste verkoper, net zoals eerder dit jaar bij de preferente aandelen Aareal. Zodra deze aandelen zijn uitverkocht, stijgt de koers. Deze verkoopt nu op 9,40 (1.500 aandelen).
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia Oyj
Nokia OYJ
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
910,69
-0,47%
EUR/USD
1,0861
+0,03%
FTSE 100
8.387,53
-0,44%
Germany40^
18.704,40
-0,34%
Gold spot
2.416,81
-0,39%
NY-Nasdaq Composite
16.794,87
+0,65%
Stijgers
Dalers